Winton Matthew - Insider Non-Derivative Transactions at Inozyme Pharma, Inc. (INZY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 28, 2024, Winton Matthew's relationship to Inozyme Pharma, Inc. (INZY) is Officer (COO), and currently has 3,188 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other INZY insiders.
Data Source: SEC.
Winton Matthew - Insider Non-Derivative Transactions at INZY
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 29, 2024 | Acquisition -- (Common Stock) | 3188 | 3.33 | 3188 |